CNL Healthcare Properties, Inc. / Fundamentals

    Income statement

    Net revenue
    €325.18M
    Cost of goods sold
    €218.87M
    Gross profit
    €106.31M
    SG&A expenses
    €34.25M
    R&D expenses
    €0.00
    EBITDA
    €53.72M
    D&A
    €44.13M
    EBIT
    €27.93M
    Interest expenses
    €38.48M
    EBT
    -€9.85M
    Tax expenses
    €591.16K
    Net income
    -€10.45M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €30.72M
    Changes in working capital
    €0.00
    Operating cash flow
    €42.99M
    Capex
    €14.81M
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€14.81M
    Total cash dividends paid
    -€11.46M
    Issuance of common stock
    €0.00
    Debt repayment
    -€8.19M
    Other financing cash flow
    -€5.13M
    Net financing cash flow
    -€24.77M
    Foreign exchange effects
    €0.00
    Net change in cash
    €3.41M
    Cash at end of period
    €47.64M
    Free cash flow
    €57.80M

    Balance sheet

    Cash and cash equivalents
    €45.63M
    Cash and short-term investments
    €45.63M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €2.00M
    Total current assets
    €47.64M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €7.98M
    Long-term investments
    €0.00
    Other non-current assets
    €1.06B
    Total non-current assets
    €1.07B
    Total assets
    €1.12B
    Accounts payable
    €23.84M
    Short-term debt
    €482.74M
    Other current liabilities
    €1.18M
    Total current liabilities
    €507.77M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €9.67M
    Total non-current liabilities
    €9.67M
    Total liabilities
    €517.44M
    Common stock
    €1.49M
    Retained earnings
    €48.21M
    Other equity
    -€750.10M
    Total equity
    €600.16M
    Total liabilities and shareholders' equity
    €1.12B

    Company information

    Market capitalization
    €533.72M
    Employees
    0
    Enterprise Value
    €467.69M

    Company ratios

    Gross margin
    32.7% Much worse than peer group: 100.1%
    EBITDA margin
    16.5% Much worse than peer group: 75.9%
    EBIT margin
    8.6% Much worse than peer group: 59.8%
    EBT margin
    -3.0% Much worse than peer group: 1,274,720.9%
    Net margin
    -3.2% Much worse than peer group: 39.9%
    ROE
    -1.7% Worse than peer group: 7.2%
    ROA
    -0.9% Worse than peer group: 5.2%
    Asset turnover
    29.1% Better than peer group: 11.6%
    FCF margin
    8.7% Even with peer group: 7.7%
    FCF yield
    5.3%
    Efficiency ratio
    83.5%
    Net sales per employee
    €0.00
    Net income per employee
    €0.00

    Notifications